 |
|
Continuing Increases in Autism Reported to California's Developmental Services SystemMercury in Retrograde
Robert Schechter, MD, MSc;
Judith K. Grether, PhD
Arch Gen Psychiatry. 2008;65(1):19-24.
Context Previous analyses of autism client data reported to the California Department of Developmental Services (DDS) have been interpreted as supporting the hypothesis that autism is caused by exposure to the preservative thimerosal, which contains ethylmercury. The exclusion of thimerosal from childhood vaccines in the United States was accelerated from 1999 to 2001. The Immunization Safety Review Committee of the Institute of Medicine has recommended surveillance of trends in autism as exposure to thimerosal during early childhood has decreased.
Objective To determine whether trends in DDS autism client data support the hypothesis that thimerosal exposure is a primary cause of autism.
Design, Setting, and Patients Study of time trends in the prevalence by age and birth cohort of children with autism who were active status clients of the DDS from January 1, 1995, through March 31, 2007.
Main Outcome Measure Prevalence of autism among children with active status in the DDS.
Results The estimated prevalence of autism for children at each year of age from 3 to 12 years increased throughout the study period. The estimated prevalence of DDS clients aged 3 to 5 years with autism increased for each quarter from January 1995 through March 2007. Since 2004, the absolute increase and the rate of increase in DDS clients aged 3 to 5 years with autism were higher than those in DDS clients of the same ages with any eligible condition including autism.
Conclusions The DDS data do not show any recent decrease in autism in California despite the exclusion of more than trace levels of thimerosal from nearly all childhood vaccines. The DDS data do not support the hypothesis that exposure to thimerosal during childhood is a primary cause of autism.
Author Affiliations: Immunization Branch (Dr Schechter) and California Center for Autism and Developmental Disabilities Research and Epidemiology, Environmental Health Investigations Branch (Dr Grether), California Department of Public Health, Richmond.
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
Thimerosal Disappears but Autism Remains
Eric Fombonne
Arch Gen Psychiatry. 2008;65(1):15-16.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Cohort effects explain the increase in autism diagnosis among children born from 1992 to 2003 in California
Keyes et al.
Int J Epidemiol 2011;0:dyr193v1-dyr193.
ABSTRACT
| FULL TEXT
Early Diagnoses of Autism Spectrum Disorders in Massachusetts Birth Cohorts, 2001-2005
Manning et al.
Pediatrics 2011;127:1043-1051.
ABSTRACT
| FULL TEXT
Prevalence of Autism Spectrum Conditions in a Youth Mental Health Service
Fraser et al.
Aust N Z J Psychiatry 2011;45:426-426.
FULL TEXT
How to Communicate With Vaccine-Hesitant Parents
Healy and Pickering
Pediatrics 2011;127:S127-S133.
ABSTRACT
| FULL TEXT
Prenatal and Infant Exposure to Thimerosal From Vaccines and Immunoglobulins and Risk of Autism
Price et al.
Pediatrics 2010;126:656-664.
ABSTRACT
| FULL TEXT
Autism Spectrum Disorders as a Qualitatively Distinct Category From Typical Behavior in a Large, Clinically Ascertained Sample
Frazier et al.
Assessment 2010;17:308-320.
ABSTRACT
Autism and Immunizations: Separating Fact From Fiction
de los Reyes
Arch Neurol 2010;67:490-492.
FULL TEXT
Prevalence of Parent-Reported Diagnosis of Autism Spectrum Disorder Among Children in the US, 2007
Kogan et al.
Pediatrics 2009;124:1395-1403.
ABSTRACT
| FULL TEXT
Neuropsychological Performance 10 Years After Immunization in Infancy With Thimerosal-Containing Vaccines
Tozzi et al.
Pediatrics 2009;123:475-482.
ABSTRACT
| FULL TEXT
Thimerosal in Vaccines: Some Reassuring Data
JWatch Pediatrics 2008;2008:1-1.
FULL TEXT
Thimerosal Disappears but Autism Remains
Fombonne
Arch Gen Psychiatry 2008;65:15-16.
FULL TEXT
|
